Company / Capital Returned to Shareholders
TEVA PHARMACEUTICAL INDUSTRIES LTD Capital Returned to Shareholders History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$12.0M
FY2018
5-year range
-
FY2016-FY2018
Trend
-98.7%
vs FY2017
Sector context
#41 of 52
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's capital returned to shareholders of $12M is lower than 79% of companies in the Health Care sector (FY2018). Declined from $1.3B to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2018.
Declined from $1.3B to $12M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 52This company $12.0M Sector average $1.3B
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2018, capital returned to shareholders decreased 98.7% year-over-year.
- Ranks #41 out of 52 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $12.0M | -98.7% |
| FY2017 | $901.0M | -30.9% |
| FY2016 | $1.3B | -18.3% |
As of FY2018 · SEC 10-K · Updated Mar 28, 2026